antagonista glp 1 Chemical structures of GLP-1 receptor antagonists. Representative A schematic overview of GLP-1

Comparison of effects of SGLT-2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus patients with/without albuminuria: a systematic review and network meta-analysis

FIGURE 8 Discussion DR is one of the leading causes of blindness among people of working age worldwide (Klein, 2007) and may become a great challenge for healthcare systems in the future (Selvaraj et al., 2017)

To view or add a comment, sign in New Publication: Sleep Quality and Patient Activation in Chronic Disease: A Cross-Sectional Mediation Analysis In this population-based study (n = 2,090, South Tyrol, Italy): - Higher patient activation (PAM-10) is modestly associated with better subjective sleep quality (Brief PSQI)

Consulte a un profesional de salud si presenta diabetes tipo 2, obesidad con comorbilidades o sntomas de hiperglucemia persistente